Mao Jianhua
Clinical trials sponsored by Mao Jianhua, explained in plain language.
-
New hope for kids with lupus? early trial tests blinatumomab
Disease control Recruiting nowThis early-phase study tests whether blinatumomab, a drug that targets certain immune cells, can safely improve symptoms in children with active lupus that hasn't responded to other treatments. Six participants will receive two short courses of the drug and be followed for a year…
Phase: PHASE1 • Sponsor: Mao Jianhua • Aim: Disease control
Last updated May 02, 2026 23:06 UTC
-
New shot could help kids with kidney disease avoid relapses
Disease control Recruiting nowThis study tests a new drug called SG301, given as a shot under the skin, for children aged 6 to 18 who have nephrotic syndrome that keeps coming back or requires steroids to stay in remission. The goal is to see if it can safely reduce relapses and help children stay off steroid…
Phase: PHASE2 • Sponsor: Mao Jianhua • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC